Product Details
| Alternative Name: | Vascular endothelial growth factor 165 |
| |
| MW: | ~45kDa |
| |
| Source: | Produced in HEK 293 cells. |
| |
| UniProt ID: | P15692 |
| |
| Formulation: | Lyophilized from 1% PBS. |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | <0.5 EU/µg |
| |
| Reconstitution: | Reconstitute in sterile 1x PBS containing 0.1% endotoxin-free recombinant human serum albumin (HSA) (ENZ-PRT204). |
| |
| Shipping: | Ambient Temperature |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. |
| |
| Scientific Background: | VEGF (Vascular endothelial growth factor) is a potent polypeptide regulator of blood vessel function. VEGF promotes an array of responses in the endothelium, including hyperpermeability, endothelial cell growth, angiogenesis, and enhanced glucose transport. Several alternate splice isoforms of VEGF are known. Two high-affinity receptors for VEGF, VEGFR1 and VEGFR2, have been identified and characterized. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Characterization of a sandwich ELISA for quantification of total human soluble neuropilin-1: E. Gadermaier, et al.; J. Clin. Lab. Anal.
33, e22944 (2019),
Abstract;
Full Text
